IP Library › Granted Patent US 7,157,452
Granted Patent B2
US 7,157,452 · App. 10/500,340 · Granted Jan 2, 2007

Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses

Assignee: MGI GP, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,452
App. No.
10/500,340
Granted
Jan 2, 2007
Kind
B2
Abstract

This invention relates to compounds, pharmaceutical compositions, and methods of using the disclosed compounds for inhibiting PARP.

Claims (3)

1. A compound selected from the group consisting of

and a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition which comprises: (i) a therapeutically effective amount of a compound according to claim 1 and (ii) a pharmaceutically acceptable carrier.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2010
From: EISAI CORPORATION OF NORTH AMERICA
To: EISAI INC.
Reel/Frame 023796/0776 →
CHANGE OF NAME Recorded Mar 13, 2009
From: MGI GP, INC.
To: EISAI CORPORATION OF NORTH AMERICA
Reel/Frame 022390/0078 →
MERGER Recorded Nov 1, 2006
From: GUILFORD PHARMACEUTICALS INC.
To: MGI GP, INC.
Reel/Frame 018468/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2004
From: LI, JIA-HE; ZHANG, JIE; KALISH, VINCENT
To: GUILFORD PHARMACEUTICALS INC.
Reel/Frame 015716/0098 →
Continuity (2)
Provisional Application 6034323200 · Dec 31, 2001
Related Publication 20040259900A1 · Dec 23, 2004